Murakami E, Akamatsu H, Teraoka S, Takakura T, Takase E, Tanaka M, Kaki T, Harutani Y, Furuta K, Sugimoto T, Shibaki R, Fujimoto D, Hayata A, Ozawa Y, Nakanishi M, Koh Y, Shimokawa T, Yamamoto N: Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration: A randomized phase II trial. Cancer Medicine 13: 1:e6839. doi: 10.1002/cam4.6839., 2024.
Kanasaki H, Ozawa Y, Nakamura N, Nagasaki K, Matsuyama W, Akahori D, Niwa M, Ogasawara T, Sato J: Upfront Multiplex Gene Test Helps Prolong Survival in Advanced Non-small Cell Lung Cancer. Anticancer Research 44: 723-730, 2024.
Ozawa Y, Koh Y, Hase T, Chibana K, Kaira K, Okishio K, Ichihara E, Murakami S, Shimokawa M, Yamamoto N: Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L) Ther Adv Med Oncol 16: 17588359231225046. doi: 10.1177/17588359231225046. eCollection, 2024.
Rudin CM, Liu SV,. Soo RA, Lu S, Hong MH, Lee JS, Bryl M, Dumoulin DW,Rittmeyer A, Chiu CH, Ozyilkan O, Johnson M, Navarro A, Novello S, Ozawa Y, Tam SH, Patil NS, Wen X, Huang M, Hoang T, Meng R, Reck M: SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer. J Clin Oncol 42: 324-335, 2024.
Takase E, Akamatsu H, Teraoka S, Nakaguchi K, Tanaka M, Taki T, Furuta K, Sato K, Murakami E, Sugimoto T, Shibaki R, Fujimoto D, Hayata A, Tokudome N, Ozawa Y, Koh Y, Nakanishi M, Kanai K, Shimokawa T, Yamamoto N: A Phase II Study of High-Flow Nasal Cannula for Relieving Dyspnea in Advanced Cancer Patients. J Pain Symptom Manage 67: 204-211, 2024.
Ozawa Y, Koh Y, Shibaki R, Harutani Y, Akamatsu H, Hayata A, Sugimoto T, Kitamura Y, Fukuoka J, Nakanishi M, Yamamoto N: Uncovering the role of tumor cGAS expression in predicting response to PD-1/L1 inhibitors in non-small cell lung cancer. Cancer Immunology, Immunotherapy 74: 7, 2024
Hiraoka Y, Nagayma K: Sacubitril/Valsartan-induced Angioedema. Internal Medicine 63: 2583, 2024.
Inui N, Suzuki T, Tanaka K, Karayama M, Inoue Y, Mori K, Yasui H, Hozumi H, Suzuki Y, Furuhashi K, Fujisawa T, Matsuura S, Nishimoto K, Matsui T, Asada K, Hashimoto D, Fujii M, Niwa M, Uehara M, Matsuda H, Koda K, Ikeda M, Inami N, Tamiya Y, Kato M, Nakano H, Mino Y, Enomoto N, Suda T: Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial. J Clin Oncol 42: 2780-2789, 2024.
学会報告
年次学術集会
Ozawa Y, Yamamoto K, Sugawara S, Niho S, Ohe Y, Okamoto H, Hotta K, Ikeda N, Yamamoto N: Comprehensive Analysis of Predictive Factors for Efficacy in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer, Utilizing Individual Patient Data from the Japan Lung Cancer Society Integrated Clinical Trial Database: Is There Room for Further Improvement? American Society of Clinical Oncology (ASCO). 2024.05.31（Chicago，一般演題）
Ozawa Y, Yamamoto K, Ito K, Kenmotsu H, Hayashi H, Shukuya T, Fujimoto D, Akamatsu H, Shimokawa T, Sugawara S, Niho S, Ohe Y, Okamoto H, Hotta K, Nishio M, Yamamoto N: The Japan Lung Society Integrated Clinical Trial Database (JIDB) and Date Sharing: Pioneering for New Possibilities. The JSMO Annual Meeting, 2024.02.01（名古屋，一般演題）
